Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 9943
TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501684(US11028058, Compound 1.309)
Affinity DataIC50: 1.60nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501676(US11028058, Compound 1.271)
Affinity DataIC50: 2.10nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501677(US11028058, Compound 1.292)
Affinity DataIC50: 2.40nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501679(US11028058, Compound 1.290)
Affinity DataIC50: 3.30nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501680(US11028058, Compound 1.295)
Affinity DataIC50: 5.5nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501682(US11028058, Compound 1.304)
Affinity DataIC50: 9nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501686(US11028058, Compound 1.318)
Affinity DataIC50: 9.40nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501681(US11028058, Compound 1.297)
Affinity DataIC50: 17nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501678(US11028058, Compound 1.288)
Affinity DataIC50: 55.5nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501675(US11028058, Compound 1.1)
Affinity DataIC50: 57nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501685(US11028058, Compound 1.315)
Affinity DataIC50: 101nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Nuvation Bio

US Patent
LigandPNGBDBM501683(US11028058, Compound 1.308)
Affinity DataIC50: 1.00E+4nMAssay Description:For the A2A adenosine receptor radioligand binding assay, the following modifications were made to the general protocol. GF/C filters (Perkin Elmer, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent